CRON Cronos Group Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: CRON

Price (delayed)

$2.4

Market cap

$915.12M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.19

Enterprise value

$246.82M

Cronos Group is an innovative global cannabinoid company with international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology ...

Highlights
Cronos Group's EPS has surged by 58% YoY and by 32% QoQ
The net income has surged by 56% year-on-year and by 32% since the previous quarter
The company's quick ratio has surged by 60% YoY but it fell by 24% QoQ
The company's debt fell by 25% YoY but it rose by 4.7% QoQ
Cronos Group's equity has decreased by 3.9% YoY
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://thecronosgroup.com

Key stats

What are the main financial stats of CRON
Market
Shares outstanding
381.3M
Market cap
$915.12M
Enterprise value
$246.82M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.83
Price to sales (P/S)
10.48
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.83
Earnings
Revenue
$87.24M
EBIT
-$128.43M
EBITDA
-$120.32M
Free cash flow
-$45.34M
Per share
EPS
-$0.19
Free cash flow per share
-$0.12
Book value per share
$2.89
Revenue per share
$0.23
TBVPS
$2.93
Balance sheet
Total assets
$1.14B
Total liabilities
$43.96M
Debt
$994,000
Equity
$1.1B
Working capital
$891.91M
Liquidity
Debt to equity
0
Current ratio
22.54
Quick ratio
21.44
Net debt/EBITDA
5.55
Margins
EBITDA margin
-137.9%
Gross margin
13.7%
Net margin
-84.8%
Operating margin
-97.2%
Efficiency
Return on assets
-6.4%
Return on equity
-6.6%
Return on invested capital
-22.1%
Return on capital employed
-11.7%
Return on sales
-147.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CRON stock price

How has the Cronos Group stock price performed over time
Intraday
-0.83%
1 week
-5.51%
1 month
7.62%
1 year
17.65%
YTD
14.83%
QTD
-8.05%

Financial performance

How have Cronos Group's revenue and profit performed over time
Revenue
$87.24M
Gross profit
$11.91M
Operating income
-$84.8M
Net income
-$73.96M
Gross margin
13.7%
Net margin
-84.8%
The net income has surged by 56% year-on-year and by 32% since the previous quarter
The company's net margin has surged by 56% YoY and by 32% QoQ
The operating margin has increased by 24% YoY and by 9% QoQ
The company's operating income rose by 24% YoY and by 7% QoQ

Growth

What is Cronos Group's growth rate over time

Valuation

What is Cronos Group stock price valuation
CRON P/E details
P/E
N/A
P/B
0.83
P/S
10.48
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.83
Cronos Group's EPS has surged by 58% YoY and by 32% QoQ
The price to book (P/B) is 40% lower than the 5-year quarterly average of 1.4 but 20% higher than the last 4 quarters average of 0.7
Cronos Group's equity has decreased by 3.9% YoY
The price to sales (P/S) is 81% lower than the 5-year quarterly average of 55.3 but 17% higher than the last 4 quarters average of 9.0

Efficiency

How efficient is Cronos Group business performance
CRON's ROE has soared by 51% YoY and by 31% QoQ
The company's return on assets has surged by 51% YoY and by 30% QoQ
The company's return on invested capital rose by 36% YoY
Cronos Group's return on sales has increased by 19% YoY

Dividends

What is CRON's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CRON.

Financial health

How did Cronos Group financials performed over time
Cronos Group's current ratio has soared by 60% YoY but it has decreased by 25% from the previous quarter
The company's quick ratio has surged by 60% YoY but it fell by 24% QoQ
The company's debt is 100% lower than its equity
The company's debt fell by 25% YoY but it rose by 4.7% QoQ
Cronos Group's equity has decreased by 3.9% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.